JP2002529066A5 - - Google Patents

Download PDF

Info

Publication number
JP2002529066A5
JP2002529066A5 JP2000581045A JP2000581045A JP2002529066A5 JP 2002529066 A5 JP2002529066 A5 JP 2002529066A5 JP 2000581045 A JP2000581045 A JP 2000581045A JP 2000581045 A JP2000581045 A JP 2000581045A JP 2002529066 A5 JP2002529066 A5 JP 2002529066A5
Authority
JP
Japan
Prior art keywords
seq
polynucleotide
ctgf
guc
cag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000581045A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002529066A (ja
JP4698837B2 (ja
Filing date
Publication date
Priority claimed from US09/187,478 external-priority patent/US6348329B1/en
Application filed filed Critical
Priority claimed from PCT/US1999/026189 external-priority patent/WO2000027868A2/en
Publication of JP2002529066A publication Critical patent/JP2002529066A/ja
Publication of JP2002529066A5 publication Critical patent/JP2002529066A5/ja
Application granted granted Critical
Publication of JP4698837B2 publication Critical patent/JP4698837B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000581045A 1998-11-06 1999-11-05 結合組織成長因子(ctgf)および使用方法 Expired - Lifetime JP4698837B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US09/187,478 US6348329B1 (en) 1998-11-06 1998-11-06 Nucleic acids encoding rat connective tissue growth factor (CTGF) and methods of use
US09/187,478 1998-11-06
US09/292,036 1999-04-14
US09/292,036 US6358741B1 (en) 1998-11-06 1999-04-14 Connective tissue growth factor (CTGF) and methods of use
PCT/US1999/026189 WO2000027868A2 (en) 1998-11-06 1999-11-05 Connective tissue growth factor (ctgf) and methods of use

Publications (3)

Publication Number Publication Date
JP2002529066A JP2002529066A (ja) 2002-09-10
JP2002529066A5 true JP2002529066A5 (https=) 2007-01-11
JP4698837B2 JP4698837B2 (ja) 2011-06-08

Family

ID=22689164

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000581045A Expired - Lifetime JP4698837B2 (ja) 1998-11-06 1999-11-05 結合組織成長因子(ctgf)および使用方法

Country Status (4)

Country Link
US (3) US6348329B1 (https=)
JP (1) JP4698837B2 (https=)
KR (1) KR20010102943A (https=)
HK (1) HK1039342A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1682699A (en) * 1997-12-25 1999-07-19 Japan Tobacco Inc. Monoclonal antibody against connective tissue growth factor and medicinal uses thereof
US7115390B1 (en) * 1998-12-14 2006-10-03 Fibrogen, Inc. Connective tissue growth factor fragments and methods and uses thereof
CN1170849C (zh) * 1998-12-14 2004-10-13 迈阿密大学 结缔组织生长因子片段及其方法和用途
US6444657B1 (en) * 1998-12-31 2002-09-03 Guilford Pharmaceuticals Inc. Methods for treating certain diseases using naaladase inhibitors
US6965025B2 (en) * 2001-12-10 2005-11-15 Isis Pharmaceuticals, Inc. Antisense modulation of connective tissue growth factor expression
US7351407B2 (en) 2002-04-30 2008-04-01 Alcon, Inc. Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies
EP1925306A3 (en) 2002-04-30 2008-09-17 Alcon, Inc. Agents which Regulate, Inhibit, or Modulate the Activity and/or Expression of Connective Tissue Growth Factor (CTGF) to Lower Intraocular Pressure
US20060074018A1 (en) * 2002-06-04 2006-04-06 Metabolex Inc Methods of diagnosing & treating diabetes and insulin resistance
US7405274B2 (en) 2003-06-04 2008-07-29 Fibrogen, Inc. Connective tissue growth factor antibodies
WO2005033136A1 (en) * 2003-09-29 2005-04-14 Children's Hospital, Inc. Unique integrin binding site in connective tissue growth factor (ctgf)
CN101884789A (zh) * 2004-02-11 2010-11-17 法布罗根股份有限公司 Ctgf作为糖尿病肾病的治疗靶点
TWI386225B (zh) * 2004-12-23 2013-02-21 Alcon Inc 用於治療眼睛病症的結締組織生長因子(CTGF)RNA干擾(RNAi)抑制技術
US20060275797A1 (en) * 2005-03-21 2006-12-07 Alcon Manufacturing, Ltd. Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders
US20100034892A1 (en) 2006-08-30 2010-02-11 The Trustees Of Columbia University In The City Of New York Treatment for bone formation disorders by growth factor delivery
US8946172B2 (en) * 2008-08-25 2015-02-03 Excaliard Pharmaceuticals, Inc. Method for reducing scarring during wound healing using antisense compounds directed to CTGF
NZ601660A (en) 2008-08-25 2014-05-30 Excaliard Pharmaceuticals Inc Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
EP2448971A1 (en) 2009-07-02 2012-05-09 Fibrogen, Inc. Methods for treatment of muscular dystrophy
US20120244169A1 (en) 2009-11-06 2012-09-27 Fibrogen, Inc. Treatment for Radiation-Induced Disorders
US20140134181A1 (en) 2010-11-05 2014-05-15 Kenneth E. Lipson Treatment Method For Lung Remodeling Diseases
PT2670411T (pt) 2011-02-02 2019-06-18 Excaliard Pharmaceuticals Inc Compostos anti sentido visando um fator de crescimento do tecido conetivo (ctfg) para utilização num método de tratamento de queloides ou cicatrizes hipertróficas
US8802839B2 (en) 2011-07-15 2014-08-12 Fibrogen, Inc. Connective tissue growth factor antisense oligonucleotides
US11299537B2 (en) 2015-12-10 2022-04-12 Fibrogen, Inc. Methods for treatment of motor neuron diseases
US20200369759A1 (en) 2019-05-23 2020-11-26 Fibrogen, Inc. Methods of treatment of muscular dystrophies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5094941A (en) 1987-12-31 1992-03-10 Zymogenetics, Inc. Monoclonal antibodies to PDGF
US5147294A (en) 1990-10-01 1992-09-15 Trustees Of Boston University Therapeutic method for reducing chronic pain in a living subject
EP0566673A1 (en) 1990-12-21 1993-10-27 Creative Biomolecules, Inc. Biosynthetic pdgf antagonists
US5770209A (en) 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
US5408040A (en) 1991-08-30 1995-04-18 University Of South Florida Connective tissue growth factor(CTGF)
US5596090A (en) * 1992-07-24 1997-01-21 The United States Of America As Represented By The Secretary Of The Navy Antisense oligonucleotides directed against human VCAM-1 RNA
US5916756A (en) 1993-12-14 1999-06-29 University Of South Florida Assay of connective tissue growth factor for detection of cell proliferative disorders
JP4537507B2 (ja) * 1997-12-25 2010-09-01 アムジェン インコーポレイテッド 結合組織増殖因子に対するモノクローナル抗体及びその医薬用途
AU1682699A (en) * 1997-12-25 1999-07-19 Japan Tobacco Inc. Monoclonal antibody against connective tissue growth factor and medicinal uses thereof

Similar Documents

Publication Publication Date Title
JP2002529066A5 (https=)
Rokeach et al. Molecular cloning of a cDNA encoding the human Sm-D autoantigen.
JP2023120412A (ja) 非組み込みウイルス送達系およびその関連方法
CN108929870B (zh) 抑制HBV的siRNA分子及其应用
EP2966170A1 (en) HBV inactivation
JP2022519761A5 (https=)
JP2025114562A (ja) 非組み込みウイルス送達システムおよびその使用の方法
JP2024511163A5 (https=)
JP2003516731A5 (https=)
CA3134944A1 (en) Engineered mrna sequences and uses thereof
JPH06500012A (ja) ウィルス(hiv)増殖抑制
JP2001503277A (ja) ウイルス変種およびその検出方法
JP2008533988A5 (https=)
JP2024511131A5 (https=)
Taylor Hepatitis delta virus
JP2021518159A5 (https=)
JP2024116343A (ja) ヘパピティスbウイルス複製およびヘパピティスbウイルス表面抗原分泌の抑制方法
JP2024503091A5 (https=)
Grötzinger et al. A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots
JP7754829B2 (ja) インビトロトランスクリプトmrna及びこれを含有する薬学組成物
WO2022217072A1 (en) Rapid drug-screening platform using crispr gain-of-function approach and pseudoviral selection assay to identify clinical biomarker and anti-viral drug targets
JPH09507062A (ja) 抗b型肝炎ウイルスオリゴヌクレオチド
JP2024534639A5 (https=)
US20230265426A1 (en) Combinatorial inhibition of mirnas for treatment of heart failure
JPH07303485A (ja) Hcvアンチセンスrna、それを含む発現ベクター、及び該rna又は発現ベクターを含むhcv関連疾患治療剤